Parameter
| Biomarker | U-Gly | Full name | Urinary glycine | Molecular Type | Metabolite |
|---|---|---|---|---|---|
| Molecular Formula | C₂H₅NO₂ | Molecular Weight | 75.07 g/mol | Core Functional Dimensions | Diagnosis, prognosis ( protective markers ) |
| Disease | Glomerulonephritis (GN) | Disease Subtypes | / | ||
| Organ | Kidney | Test Sample / Technology Platform | Urine ( Nuclear Magnetic Resonance Metabolomics ) | ||
| Pathobiological Mechanisms | Through nuclear magnetic resonance metabolomics identification, urinary glycine level is associated with IgAN and is a protective biomarker for IgAN. | ||||
| Clinical Availability Status | Research verification stage: The characteristics of protective markers are clear and need clinical verification. | ||||
| Notes and Dynamics | It provides new metabolic markers for early IgAN diagnosis and Prognostic judgment, and is protective and may become a target for intervention. | ||||